CollPlant Biotechnologies Ltd.
CLGN
$1.90
$0.3724.18%
NASDAQ
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -- | -136.63% | -158.80% | -159.48% | |
| Total Depreciation and Amortization | -- | -5.81% | -2.88% | -2.14% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | -19.77% | -18.70% | -12.18% | |
| Change in Net Operating Assets | -- | -143.87% | 446.77% | 211.31% | |
| Cash from Operations | -- | -410.06% | -244.69% | 79.96% | |
| Capital Expenditure | -- | 49.37% | 35.47% | 29.87% | |
| Sale of Property, Plant, and Equipment | -- | -98.53% | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | 78.89% | -252.63% | -201.12% | |
| Cash from Investing | -- | 53.37% | 21.60% | 18.08% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | -99.19% | -99.40% | -82.59% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | -- | -99.19% | -99.40% | -82.59% | |
| Foreign Exchange rate Adjustments | -- | 62.53% | 99.38% | 45.85% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -362.85% | -260.77% | 73.74% | |